Related Experiment Video
Updated: May 10, 2025
Extraction and Purification of Polyphenols from Freeze-dried Berry Powder for the Treatment of Vascular Smooth Muscle Cells In Vitro
Published on: July 5, 2017
Therapeutic potential of natural flavonoids in atherosclerosis through endothelium-protective mechanisms: An update
Chao Zhong1, Keke Deng1, Xiaoya Lang1
1Center for Translational Medicine, Discipline of Chinese and Western Integrative Medicine, Jiangxi University of Chinese Medicine, Nanchang 330004, China.
Insights
Natural flavonoids show promise in combating atherosclerosis by protecting endothelial cells from dysfunction. This review explores their mechanisms and potential as future cardiovascular therapeutics.
Area of Science:
- Cardiovascular Research
- Pharmacology
- Natural Products Chemistry
Background:
- Atherosclerosis and cardiovascular diseases are major global health concerns.
- Endothelial dysfunction is a critical factor in atherosclerosis development and progression.
- Targeting endothelial dysfunction offers a promising therapeutic strategy for atherosclerosis.
Purpose of the Study:
- To review the role of natural flavonoids in mitigating endothelial dysfunction.
- To summarize the anti-atherosclerotic effects of flavonoids and their molecular mechanisms.
- To discuss the clinical translation of flavonoids for cardiovascular medicine.
Main Methods:
- Literature review of studies on natural flavonoids and endothelial function.
- Analysis of molecular mechanisms underlying flavonoid action on endothelial cells.
- Synthesis of evidence on therapeutic effects in atherosclerosis models.
Main Results:
- Flavonoids demonstrate significant potential in protecting endothelial cells and reducing atherosclerosis.
- Various flavonoids modulate key pathways involved in endothelial dysfunction.
- Evidence supports flavonoids as endothelium-protective agents against atherosclerosis.
Conclusions:
- Natural flavonoids are potent modulators of endothelial dysfunction, offering therapeutic benefits for atherosclerosis.
- Further research is needed to overcome challenges in translating flavonoid-based therapies into clinical practice.
- Flavonoids represent a promising avenue for developing novel endothelium-protective pharmacotherapies for cardiovascular disease.
Abstract:
Atherosclerosis and its associated cardiovascular complications remain significant global public health challenges, underscoring the urgent need for effective therapeutic strategies. Endothelial cells are critical for maintaining vascular health and homeostasis, and their dysfunction is a key contributor to the initiation and progression of atherosclerosis. Targeting endothelial dysfunction has, therefore, emerged as a promising approach for the prevention and management of atherosclerosis. Among natural products, flavonoids, a diverse class of plant-derived phenolic compounds, have garnered significant attention for their anti-atherosclerotic properties. A growing body of evidence demonstrates that flavonoids can mitigate endothelial dysfunction, highlighting their potential as endothelial dysfunction-targeted therapeutics for atherosclerosis. In this review, we summarize current knowledge on the roles of natural flavonoids in modulating various aspects of endothelial dysfunction and their therapeutic effects on atherosclerosis, focusing on the underlying molecular mechanisms. We also discuss the challenges and future prospects of translating natural flavonoids into clinical applications for cardiovascular medicine. This review aims to provide critical insights to advance the development of novel endothelium-protective pharmacotherapies for atherosclerosis.
More Related Videos
Related Concept Videos
01:16Antianginal Drugs: Nitrates and β-Blockers
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
01:31Lipid-derived Compounds in the Human Body
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin,...
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents